Green Thumb Industries Inc.

Green Thumb Industries Inc. Earnings Recaps

GTBIF Health Care 1 recap
Next earnings: November 4, 2026 (estimated) · full calendar
Q2 2026 Aug 7, 2026

Shares of Green Thumb Industries fell 5.5% after the earnings release, driven by investor concerns around continued price compression and a cautious outlook despite stable revenue growth.

Key takeaways
  • Q2 revenue grew 5% year-over-year to $307 million, reflecting underlying business scale but modest top-line momentum.
  • Normalized EBITDA reached $84 million, or approximately 28% of revenue, indicating margin pressure amid ongoing price compression.
  • Cash flow from operations was $29 million, supporting ongoing share repurchases totaling roughly $200 million returned since late 2023.
  • Management highlighted regulatory progress and potential federal rescheduling as long-term catalysts, but provided no firm near-term guidance upgrades.
  • Early signs of price stabilization in select markets were noted, though competitive dynamics and price pressure persist, keeping near-term outlook cautious.